Compare Cardinal Health Inc (CAH) vs Nvidia Corp (NVDA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Nvidia Corp — how do they compare? Cardinal Health Inc trades at $225.23 (market cap $53.89B), while Nvidia Corp trades at $211.61 (market cap $5.13T). The key difference: Nvidia Corp is far larger — about 95.2× Cardinal Health Inc's market cap, and Cardinal Health Inc pays the higher dividend (0.89%). Which is the better fit depends on your goals.
| CAH | NVDA | |
|---|---|---|
Market Cap | $53.89B | $5.13T |
Sector | Health | Technology |
52-Week High | $239.71 | $235.75 |
52-Week Low | $146.04 | $165.17 |
Enterprise Value | $58.87B | $5.06T |
Dividend Yield | 0.89% | 0.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
NVIDIA (NVDA) trades at $209.30, up 2.83% today, with strong bullish technical signals from moving averages and a consensus analyst price target of $325.86. The company reported exceptional fundamentals with Q1 2026 EPS beating expectations at $1.87, revenue surging to $130.50 billion in 2025, and net income margins expanding to 62.97%. Recent news highlights AI-driven growth potential but notes concerns about peak spending and competition.
Outlook remains positive given dominant AI market position and accelerating revenue, though risks include high valuations (P/E 32.43), competitive pressures, and market volatility. Institutional sentiment is strongly bullish with 75% buy ratings, supporting long-term growth prospects if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →
